Alaunos Therapeutics, Inc.
Balance Sheet
| Line Item | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 |
|---|---|---|---|---|---|---|---|---|
| Assets | ||||||||
| Cash & Equivalents | $1.4M | $1.1M | $6.1M | $39.1M | $76.1M | $115.1M | $79.7M | $61.7M |
| Accounts Receivable | $3.0K | $5.0K | $1.0K | $4.0K | $1.1M | $4.7M | $3.3M | $1.9M |
| Inventory | — | — | — | — | — | — | — | — |
| Total Current Assets | $2.0M | $2.8M | $8.3M | $53.8M | $78.8M | $130.6M | $105.5M | $84.3M |
| Property, Plant & Equipment | $91.0K | $0 | $2.0K | $8.5M | $10.9M | $10.2M | $1.1M | $1.1M |
| Goodwill | — | — | — | — | — | — | — | — |
| Intangible Assets (Excl. Goodwill) | — | — | — | — | — | — | — | — |
| Total Assets | $3.0M | $2.8M | $8.3M | $64.9M | $94.9M | $146.3M | $109.1M | $95.1M |
| Liabilities | ||||||||
| Accounts Payable | $613.0K | $516.0K | $616.0K | $1.4M | $1.4M | $960.0K | $906.0K | $707.0K |
| Total Current Liabilities | $813.0K | $692.0K | $2.0M | $24.2M | $16.0M | $18.4M | $12.5M | $9.5M |
| Long-Term Debt | — | $0 | $0 | $0 | $16.3M | $0 | — | — |
| Total Liabilities | $813.0K | $692.0K | $2.0M | $26.4M | $36.8M | $22.4M | $14.1M | $9.5M |
| Stockholders' Equity | ||||||||
| Retained Earnings | $-924.6M | $-920.4M | $-915.8M | $-880.6M | $-842.9M | $-764.1M | $-684.1M | $-566.3M |
| Total Stockholders' Equity | $2.2M | $2.1M | $6.3M | $38.6M | $58.1M | $124.0M | $95.0M | $85.6M |